Last updated: 03/09/2024
225
|
total admissions. |
This information has been verified as accurate by the consultant
This information is provided by Professor Prof Marco Gerlinger.
GMC reg: 6117372Chair of Gastrointestinal Cancer Medicine at St Bartholomew’s Hospital, London Clinician Scientist and Head of the Translational Cancer Immunotherapy and Genomics Lab, Barts Cancer Institute Chief and Principle Investigator of clinical trials investigating novel immunotherapies and treatment personalisation approaches in colorectal and gastro-oesophageal cancer In my private clinics at LOC Harley Street and Nuffield St Barts Hospital, I provide evidence based care for patients with bowel and gastro-oesophageal cancers utilising the latest advances in therapeutics and biomarker development.
PHIN is not responsible for the content of third-party sites.
Medical oncology
German
Stomach cancer / gastric cancer Oesophageal cancer Cancer of the gastro-oesophageal junction Colorectal cancer / bowel cancer Small bowel cancer Anal cancer Chemotherapy Immunotherapy Targeted therapies Antibody drug conjugates Clinical trials Personalised cancer medicine Advanced genetic tumour testing Treatment optimisation by circulating tumour DNA testing/minimal residual disease testing
Surveys from patients about the care they received from Professor Prof Marco Gerlinger.
…
|
Not enough data available to show patient satisfaction feedback. |
…
|
Not enough data available to show patient experience feedback. |
Leaders of Oncology Care at 95 Harley Street
Leaders of Oncology Care at Sydney Street
Leaders of Oncology Centre at The Platinum Medical Centre
Nuffield Health at St Bartholomew’s Hospital
Use our interactive chart to explore more fees information in your area .